Ro cuts Body membership price
- Telehealth provider Ro sharply reduced its 'Body' membership pricing, claiming big annual savings for users. - The company says the new pricing cuts about $900 per year compared with previous costs. - The move shows telehealth channels changing access and price for weight‑management care through subscription models (x.com).
Ro has cut the price of its Body membership to as low as $74 a month on an annual prepay plan, down from $149 a month. (ro.co) Ro’s pricing page says the program now costs $39 for the first month, then $149 a month on a month-to-month plan or as low as $74 a month if patients prepay for a year. The company says medication is billed separately and members are charged only if they are approved for treatment. (ro.co) The math behind Ro’s savings claim comes from that annual plan: $74 a month for 12 months is $888, versus $1,788 at $149 a month, a difference of $900 a year. Ro had already lowered the first-month fee to $45 in a May 22, 2025 announcement tied to Novo Nordisk’s $199 first-month Wegovy offer. (ro.co) (prnewswire.com) Body is Ro’s subscription layer around obesity treatment: online visits with a licensed provider, insurance paperwork, coaching, labs when appropriate, side-effect monitoring, and messaging in the app. The drugs themselves, including Wegovy and Zepbound, sit on top of that membership fee. (ro.co) (prnewswire.com) That pricing shift lands in a market where telehealth companies are trying to turn weight-loss care into a recurring subscription business built around glucagon-like peptide-1 drugs, or GLP-1s, the class that includes semaglutide and tirzepatide. Novo Nordisk said in April 2025 that it expanded Wegovy access through telehealth partners including Ro, Hims & Hers, and LifeMD via NovoCare Pharmacy. (novocare.com) (prnewswire.com) Ro is also using the lower membership fee to match the direct-pay drug channels run by manufacturers. Its pricing page says cash-pay patients can get Food and Drug Administration-approved GLP-1s at the same prices as LillyDirect, NovoCare, and TrumpRx, with extra savings available through annual prepayment. (ro.co) Competitors are moving on similar price points. Hims launched a GLP-1 weight-loss membership in April 2026 at $39 for the first month and $149 a month after that, the same monthly rate Ro now charges only if a patient does not prepay. (usatoday.com) (mensjournal.com) Ro has been leaning harder on obesity care as the business grows. Ro’s own press page highlights repeated weight-loss announcements through 2025 and 2026, and outside estimates from Sacra said Ro reached about $598 million in annualized revenue in 2024, driven largely by Ro Body. (ro.co) (sacra.com) The immediate effect is simple: Ro is asking patients to commit up front in exchange for a much lower monthly membership bill. In the GLP-1 market, price now depends not just on the drug, but on which telehealth gatekeeper handles the prescription, support, and insurance fight. (ro.co)
